Annals of internal medicine

Benefits and Risks of Drug Treatments for Adults with Overweight or Obesity

Updated

Abstract

A total of 112,511 participants were included in the review of pharmacologic treatments for weight management.

  • Sixty-nine studies were analyzed, with nearly all interventions showing greater effectiveness in weight reduction compared to placebo and/or lifestyle intervention.
  • Semaglutide is associated with a probable reduction in mortality and major adverse cardiovascular events.
  • Semaglutide and tirzepatide resulted in the greatest weight loss when compared to placebo and/or lifestyle intervention.
  • Limited evidence was found for outcomes related to mortality, major adverse cardiovascular events, and serious adverse events.
  • Thirty-seven studies were considered to be at low risk of bias.

Simplified

Full Text

Full text is available at the source.

Funding

Competing interests

Disclosures: Disclosure forms are available with the article online.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free